In a 65-year-old patient with systolic blood pressure in the 150s while taking Lotrel (lisinopril/hydrochlorothiazide) 5 mg/10 mg, what is the next step in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intensify Antihypertensive Therapy by Increasing Lotrel Dose or Adding a Third Agent

For this 65-year-old patient with SBP in the 150s on Lotrel 5/10 mg, you should intensify therapy by either increasing the Lotrel dose or adding a third antihypertensive medication to achieve better blood pressure control.

Rationale Based on Current Guidelines

The 2017 ACC/AHA guidelines 1 classify this patient as having Stage 2 hypertension (SBP ≥140 mm Hg) and recommend combination therapy with two agents of different classes, which this patient is already receiving. However, the current regimen is clearly inadequate given the persistent SBP in the 150s.

Key Considerations for Target Blood Pressure

There is important divergence in guidelines for patients over 60:

  • ACC/AHA 2017 1: Recommends target SBP <130 mm Hg for most adults, including those ≥65 years
  • ACP/AAFP 2017 2: Recommends target SBP <150 mm Hg for adults ≥60 years (strong recommendation), with consideration for <140 mm Hg in high cardiovascular risk patients (weak recommendation)

Given that this patient's SBP is in the 150s, they are above target by BOTH guidelines, making intensification clearly indicated regardless of which guideline you follow.

Specific Treatment Options

Option 1: Increase Lotrel Dose (Preferred Initial Step)

Lotrel contains benazepril (ACE inhibitor) and amlodipine (calcium channel blocker). Current dose is 5/10 mg, which is relatively low:

  • Benazepril usual dose range: 10-40 mg daily 1
  • Amlodipine usual dose range: 2.5-10 mg daily 1

Recommended action: Increase to Lotrel 10/10 mg or 10/20 mg, as the benazepril component is at the lower end of the therapeutic range 3.

Option 2: Add a Thiazide-Like Diuretic

If dose escalation is insufficient or not tolerated, add:

  • Chlorthalidone 12.5-25 mg daily (preferred over hydrochlorothiazide based on prolonged half-life and proven CVD reduction) 1
  • This creates a three-drug regimen: ACE inhibitor + CCB + thiazide-like diuretic

The combination of lisinopril (similar ACE inhibitor) with hydrochlorothiazide has demonstrated effectiveness in elderly patients with systolic hypertension 4.

Important Safety Monitoring

Before intensifying therapy, verify:

  • Renal function: Monitor creatinine and potassium, especially when increasing ACE inhibitor dose 3
  • Orthostatic vital signs: Assess for symptomatic hypotension risk, particularly in elderly patients 3
  • Medication adherence: Confirm the patient is actually taking the current regimen consistently
  • Accurate BP measurement: Consider ambulatory or home BP monitoring to rule out white coat hypertension 2

Common Pitfalls to Avoid

  1. Don't accept SBP in the 150s as adequate - this patient needs better control regardless of age
  2. Don't add potassium-sparing diuretics without careful monitoring, as ACE inhibitors already increase hyperkalemia risk 1
  3. Monitor for pedal edema with amlodipine dose increases (dose-related, more common in women) 1
  4. Watch for cough with benazepril escalation (common ACE inhibitor side effect) 2

Follow-Up Timeline

Reassess BP in 1 month after medication adjustment 1. This is the recommended interval for patients with Stage 2 hypertension on combination therapy requiring intensification.

Cardiovascular Risk Assessment

Consider calculating 10-year ASCVD risk to determine if this patient falls into the high-risk category (≥10%), which would further support targeting SBP <130-140 mm Hg rather than accepting <150 mm Hg 1, 2. Patients with history of stroke/TIA or established cardiovascular disease warrant more aggressive targets of <140 mm Hg 2.

Related Questions

What are the guidelines for starting antihypertensive treatment in individuals over 60 with hypertension?
In a 65-year-old Hispanic woman with obesity who is initiating antihypertensive therapy for the first time, which medication is the safest option?
Is a 65-year-old man with multiple asymptomatic blood pressure readings of 140/90 mm Hg considered to have normal blood pressure for his age?
At what blood pressure thresholds should antihypertensive therapy be initiated in adults, including those with diabetes, chronic kidney disease, established cardiovascular disease, and patients older than 65 years?
In a 68-year-old patient with systolic blood pressure readings of 150‑166 mmHg and new inner thigh/leg tightness causing difficulty rising, how should I manage his hypertension and evaluate the leg symptoms?
What is the interpretation of a hemoglobin of 11.2 g/dL, mean corpuscular hemoglobin (MCH) of 25.8 pg, and mean corpuscular hemoglobin concentration (MCHC) of 30.8 g/dL?
What is the recommended dosing, administration, contraindications, and alternative options for viscous lidocaine as a topical anesthetic?
What topical agents are safe and appropriate for managing severe shoulder pain?
What nasal corticosteroid and dosing regimen should be used in an adult with allergic rhinitis or chronic rhinosinusitis?
How should a serum potassium of 5.2 mEq/L be managed?
What is the appropriate evaluation and management for persistent hypertriglyceridemia in a patient who follows a low‑simple‑carbohydrate, low‑alcohol, omega‑3‑rich diet?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.